IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer

Links shared publicly online about this topic.

802
total visits

IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer

IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.

View full resource at news-medical.net

Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Lung, News, Radiation

Most Recently Shared on October 14, 2010 at 3:58 pm By:

News-Medical.Net

Lung Cancer News: IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer: IsoRay, Inc. announce... http://bit.ly/c7t18O

1 year ago...

Retweet

Favorite

IsoRay initiates study of Cesium-131 brachytherapy seeds in NSCLC cancer

news-medical.net — “IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.” View full resource at news-medical.net